American Joint Committee on Cancer. (2002). American Joint Committee on Cancer Cancer Staging Manual, ed. et al., 6th edn. New York: Springer.
1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J. Clin. Oncol., 16, 1310–17., , et al. (
2004). Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. (European Organisation for Research and Treatment of Cancer Trial 22931). N. Engl. J. Med., 350, 1945–52., , et al. (
2004). Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: a phase III study of high dose radiation therapy with or without cetuximab. J. Clin. Oncol., American Society of Clinical Oncology Annual Meeting Proceedings (Post-Meeting Edition). Vol. 22 (14 Suppl.), 5507., , et al. (
2002). Conventional vs modified fractionated radiotherapy. Meta-analysis of radiotherapy in head and neck sqamous carcinoma: a meta-analysis based on individual patient data. Int. J. Radiat. Oncol. Biol. Phys., 54 (Suppl.), 71–2., , et al. (
British Association of Otorhinolaryngologists – Head and Neck Surgeons. (2002). Effective Head and Neck Cancer Management: Third Consensus Document. London: Royal College of Surgeons.
2004). Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 350, 1937–44., , et al. (
Cancer Research United Kingdom. (2004) CancerStats Monograph 2004: Cancer Incidence, Survival and Mortality in the United Kingdom and European Union, ed. . London: Cancer Research United Kingdom.
1997). A randomised multicentre trial of continuous hyperfractionated accelerated radiotherapy versus conventional radiotherapy in head and neck cancer. Radiother. Oncol., 44, 123–36., , et al. (
1992). Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the European Organisation for Research and Treatment of Cancer cooperative group of radiotherapy. Radiother. Oncol., 25, 231–41., , et al. (
Intercollegiate Standing Committee on Nuclear Medicine. (2003). Positron Emission Tomography: A Strategy for Provision in the United Kingdom. London: Royal College of Physicians.
2002). End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann. Oncol., 13, 995–1006., , et al. (
National Institute for Health and Clinical Excellence. (2004). Improving Outcomes in Head and Neck Cancers. London: National Institute for Health and Clinical Excellence.
2003). Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: Danish Head and Neck Cancer 6 and 7 randomised controlled trial. Lancet, 362, 933–40., , et al. (
2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group MetaAnalysis of chemotherapy on head and neck cancer. Lancet, 355, 949–55., , et al. (
Royal College of Radiologists. (2001). The Role and Development of Brachytherapy Services in the United Kingdom. London: Royal College Radiologists.
1978). International Histological Classification of Tumours, No 19: Histological Typing of Upper Respiratory Tract Tumors. Geneva: World Health Organization, p. 32. and (
International Union Against Cancer. (2002). tumour nodes metastases Classification of Malignant Tumours, ed. and , 6th edn. New York: Wiley-Liss.